RNRCTNursing research2024

Intervention Fidelity in a Virtual Community Participatory Research Trial.

Holly J Jones, Tamilyn Bakas, Patricia Bacchus and 2 others

PMID 39103305

WHAT IT FOUND

Fidelity monitoring helped deliver a virtual stress-reduction program to midlife Black women, but lifestyle improvements faded by 12 weeks.

Nurses should plan for ongoing support and address technology barriers, as engagement and enactment were inconsistent.

Key findings

01Lifestyle improvements seen at 8 weeks in the B-SWELL group trended back to baseline by week 12, indicating a lack of sustained enactment.

02Inter-rater reliability for the engagement tool (VAAT) was inconsistent across time due to a lack of calibration training.

03Participants reported high satisfaction and engagement, but the only significant difference in surveys was related to orientation on the Zoom platform.

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study was a feasibility trial with a small sample size, limiting the generalizability of the findings. Inter-rater reliability for the engagement tool was inconsistent due to a lack of pre-program calibration. Technical issues resulted in missing data for weekly feedback surveys. Personal goals were not specifically tracked, limiting the assessment of long-term enactment. The paper does not state the exact number of participants recruited or analyzed.

Declared interests

All authors declared no conflicts of interest. The research was supported by the N.I.H. and non-U.S. government funds.

The easy way to misread this

Do not interpret the high satisfaction and engagement scores as evidence that the intervention produced lasting cardiovascular health benefits. The lifestyle improvements observed at 8 weeks trended back to baseline by week 12, and the study was a feasibility trial focused on fidelity monitoring rather than confirming efficacy.

Read it on PubMed →